Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.79942 | 34 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.68026 | 30 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.67993 | 30 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.61133 | 29 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.61496 | 29 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.7828 | 31 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.85091 | 35 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.65847 | 30 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.63326 | 29 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.67499 | 30 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.66357 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.6419 | 30 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.67228 | 30 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.67024 | 30 |